Featured Research

from universities, journals, and other organizations

Overuse of radioactive iodine for thyroid cancer highest in regions with poor health care access

Date:
October 16, 2013
Source:
American Thyroid Association
Summary:
Socioeconomic factors used to rank the different geographic regions that together are associated with higher use of radioactive iodine (RAI). These factors include significantly lower levels of income, education, and white collar employment.

The American Thyroid Association (ATA) recommends against the routine use of radioactive iodine after surgery to remove the thyroid in patients with low-risk papillary thyroid cancer (PTC). Yet more than 30% of these patients receive radioactive iodine (RAI) treatment in the U.S. A new study presented at the upcoming annual meeting of the ATA finds that overutilization of RAI is more common in regions of the country where people have worse access to health care.

Related Articles


J. Marti and colleagues from Beth Israel Medical Center and Memorial Sloan-Kettering Cancer Center, New York, NY analyzed more than 13,000 cases of very low risk classical PTC across the U.S. in which patients underwent total thyroidectomy. They report that patterns of RAI use in these patients vary dramatically. Over a 19-year period, the proportion of patients who received RAI ranged from 30-36%.

In a presentation entitled "Overutilization of RAI for Very Low Risk Thyroid Cancer Is Most Frequent in Regions with Poorer Healthcare Access," the researchers describe a composite of socioeconomic factors used to rank the different geographic regions that together are associated with higher use of RAI. These factors include significantly lower levels of income, education, and white collar employment, and higher levels of uninsured, non-English speaking, and poor persons. The people living in these regions have poorer access to health care and, likely, to experienced specialists.

This study will be presented as part of an oral presentation delivered at the 83rd Annual Meeting of the American Thyroid Association, October 16-20, 2013, in San Juan, Puerto Rico.

"Radioiodine therapy has potential toxicity and financial costs, yet a substantial number of low risk thyroid cancer patients receive this therapy despite little to no chance of benefit," says Ronald J. Koenig, M.D., Ph.D., Program Committee Co-Chair, and Professor, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor. "In order to minimize the overuse of RAI, it is first necessary to identify the factors that lead to this overuse. The study by Marti and colleagues helps to do this, identifying socioeconomic factors that correlate with RAI overuse. Importantly, their data suggest the problem may be inadequate access to appropriate specialists, a problem that should be remediable."


Story Source:

The above story is based on materials provided by American Thyroid Association. Note: Materials may be edited for content and length.


Cite This Page:

American Thyroid Association. "Overuse of radioactive iodine for thyroid cancer highest in regions with poor health care access." ScienceDaily. ScienceDaily, 16 October 2013. <www.sciencedaily.com/releases/2013/10/131016095847.htm>.
American Thyroid Association. (2013, October 16). Overuse of radioactive iodine for thyroid cancer highest in regions with poor health care access. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2013/10/131016095847.htm
American Thyroid Association. "Overuse of radioactive iodine for thyroid cancer highest in regions with poor health care access." ScienceDaily. www.sciencedaily.com/releases/2013/10/131016095847.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins